Cancer Treatment Drugs Market 2027 By Product Type, Application and Geography | The Insight Partners

Cancer Treatment Drugs Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product Type (Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy) ; Application (Blood Cancer, Breast Cancer, Lung Cancer, Stomach Cancer, Colorectal Cancer, Prostate Cancer, Esophagus Cancer, Liver Cancer, Cervical Cancer, Bladder Cancer, Kidney Cancer, Others) and Geography

Report Code: TIPRE00008658 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Anticancer drugs or anticancer agents are drugs that work in different ways to either destroy the cancer cells or slow the growth of cancer cells. Chemotherapy destroys the cancer cells as well as slows their growth. Hormonal drug therapy reduces the growth of cancers such as breast, prostate, and uterine cancer which uses sex hormones like estrogen, progesterone, and testosterone to grow. Immunotherapy restores the immune system of the patient's body to fight cancer. Drugs that target a molecule like protein or other to stop the growth of cancer cells is termed as targeted therapy.

MARKET DYNAMICS

Cancer treatment drugs market is anticipated to grow in the forecast period owing to increasing prevalence of cancer, extensive research and development activities to produce novel drugs for the treatment, and early detection and increasing awareness about the disease. Moreover, inorganic strategies by the market players like collaborations, mergers, and acquisitions by the market players are likely to create opportunities during the forecast period.

MARKET SCOPE

The "Global Cancer Treatment Drugs market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of cancer treatment drugs market with detailed market segmentation by product type, application and geography. The global cancer treatment drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cancer treatment drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global cancer treatment drugs market is segmented on the basis of product type and application. Based on product type, the market is segmented as chemotherapy, targeted therapy, immunotherapy, and hormonal therapy. Based on indication, the market is segmented as blood cancer, breast cancer, lung cancer, stomach cancer, colorectal cancer, prostate cancer, esophagus cancer, liver cancer, cervical cancer, bladder cancer, kidney cancer, and others.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Cancer Treatment Drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cancer treatment drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cancer treatment drugs market from both demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Cancer Treatment Drugs market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the cancer treatment drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Cancer Treatment Drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for Cancer treatment drugs market in the global market. Below mentioned is the list of few companies engaged in the cancer treatment drugs market.

The report also includes the profiles of key Cancer Treatment Drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- AbbVie Inc.
- Astellas Pharma Inc.
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Celgene Corporation
- F Hoffmann-La Roche ltd.
- Johnson & Johnson (Janssen Global Services, LLC,)
- Merck & Co., Inc.
- Novartis AG
- Pfizer Inc

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cancer Treatment Drugs Market - By Product Type
1.3.2 Cancer Treatment Drugs Market - By Application
1.3.3 Cancer Treatment Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. CANCER TREATMENT DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. CANCER TREATMENT DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CANCER TREATMENT DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. CANCER TREATMENT DRUGS - GLOBAL MARKET OVERVIEW
6.2. CANCER TREATMENT DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. CANCER TREATMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. CHEMOTHERAPY
7.3.1. Overview
7.3.2. Chemotherapy Market Forecast and Analysis
7.4. TARGETED THERAPY
7.4.1. Overview
7.4.2. Targeted Therapy Market Forecast and Analysis
7.5. IMMUNOTHERAPY
7.5.1. Overview
7.5.2. Immunotherapy Market Forecast and Analysis
7.6. HORMONAL THERAPY
7.6.1. Overview
7.6.2. Hormonal Therapy Market Forecast and Analysis
8. CANCER TREATMENT DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. BLOOD CANCER
8.3.1. Overview
8.3.2. Blood Cancer Market Forecast and Analysis
8.4. BREAST CANCER
8.4.1. Overview
8.4.2. Breast Cancer Market Forecast and Analysis
8.5. LUNG CANCER
8.5.1. Overview
8.5.2. Lung Cancer Market Forecast and Analysis
8.6. STOMACH CANCER
8.6.1. Overview
8.6.2. Stomach Cancer Market Forecast and Analysis
8.7. COLORECTAL CANCER
8.7.1. Overview
8.7.2. Colorectal Cancer Market Forecast and Analysis
8.8. PROSTATE CANCER
8.8.1. Overview
8.8.2. Prostate Cancer Market Forecast and Analysis
8.9. ESOPHAGUS CANCER
8.9.1. Overview
8.9.2. Esophagus Cancer Market Forecast and Analysis
8.10. LIVER CANCER
8.10.1. Overview
8.10.2. Liver Cancer Market Forecast and Analysis
8.11. CERVICAL CANCER
8.11.1. Overview
8.11.2. Cervical Cancer Market Forecast and Analysis
8.12. BLADDER CANCER
8.12.1. Overview
8.12.2. Bladder Cancer Market Forecast and Analysis
8.13. KIDNEY CANCER
8.13.1. Overview
8.13.2. Kidney Cancer Market Forecast and Analysis
8.14. OTHERS
8.14.1. Overview
8.14.2. Others Market Forecast and Analysis
9. CANCER TREATMENT DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cancer Treatment Drugs Market Overview
9.1.2 North America Cancer Treatment Drugs Market Forecasts and Analysis
9.1.3 North America Cancer Treatment Drugs Market Forecasts and Analysis - By Product Type
9.1.4 North America Cancer Treatment Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Cancer Treatment Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cancer Treatment Drugs Market
9.1.5.1.1 United States Cancer Treatment Drugs Market by Product Type
9.1.5.1.2 United States Cancer Treatment Drugs Market by Application
9.1.5.2 Canada Cancer Treatment Drugs Market
9.1.5.2.1 Canada Cancer Treatment Drugs Market by Product Type
9.1.5.2.2 Canada Cancer Treatment Drugs Market by Application
9.1.5.3 Mexico Cancer Treatment Drugs Market
9.1.5.3.1 Mexico Cancer Treatment Drugs Market by Product Type
9.1.5.3.2 Mexico Cancer Treatment Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Cancer Treatment Drugs Market Overview
9.2.2 Europe Cancer Treatment Drugs Market Forecasts and Analysis
9.2.3 Europe Cancer Treatment Drugs Market Forecasts and Analysis - By Product Type
9.2.4 Europe Cancer Treatment Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Cancer Treatment Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cancer Treatment Drugs Market
9.2.5.1.1 Germany Cancer Treatment Drugs Market by Product Type
9.2.5.1.2 Germany Cancer Treatment Drugs Market by Application
9.2.5.2 France Cancer Treatment Drugs Market
9.2.5.2.1 France Cancer Treatment Drugs Market by Product Type
9.2.5.2.2 France Cancer Treatment Drugs Market by Application
9.2.5.3 Italy Cancer Treatment Drugs Market
9.2.5.3.1 Italy Cancer Treatment Drugs Market by Product Type
9.2.5.3.2 Italy Cancer Treatment Drugs Market by Application
9.2.5.4 Spain Cancer Treatment Drugs Market
9.2.5.4.1 Spain Cancer Treatment Drugs Market by Product Type
9.2.5.4.2 Spain Cancer Treatment Drugs Market by Application
9.2.5.5 United Kingdom Cancer Treatment Drugs Market
9.2.5.5.1 United Kingdom Cancer Treatment Drugs Market by Product Type
9.2.5.5.2 United Kingdom Cancer Treatment Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cancer Treatment Drugs Market Overview
9.3.2 Asia-Pacific Cancer Treatment Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Cancer Treatment Drugs Market Forecasts and Analysis - By Product Type
9.3.4 Asia-Pacific Cancer Treatment Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cancer Treatment Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cancer Treatment Drugs Market
9.3.5.1.1 Australia Cancer Treatment Drugs Market by Product Type
9.3.5.1.2 Australia Cancer Treatment Drugs Market by Application
9.3.5.2 China Cancer Treatment Drugs Market
9.3.5.2.1 China Cancer Treatment Drugs Market by Product Type
9.3.5.2.2 China Cancer Treatment Drugs Market by Application
9.3.5.3 India Cancer Treatment Drugs Market
9.3.5.3.1 India Cancer Treatment Drugs Market by Product Type
9.3.5.3.2 India Cancer Treatment Drugs Market by Application
9.3.5.4 Japan Cancer Treatment Drugs Market
9.3.5.4.1 Japan Cancer Treatment Drugs Market by Product Type
9.3.5.4.2 Japan Cancer Treatment Drugs Market by Application
9.3.5.5 South Korea Cancer Treatment Drugs Market
9.3.5.5.1 South Korea Cancer Treatment Drugs Market by Product Type
9.3.5.5.2 South Korea Cancer Treatment Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cancer Treatment Drugs Market Overview
9.4.2 Middle East and Africa Cancer Treatment Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Cancer Treatment Drugs Market Forecasts and Analysis - By Product Type
9.4.4 Middle East and Africa Cancer Treatment Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cancer Treatment Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cancer Treatment Drugs Market
9.4.5.1.1 South Africa Cancer Treatment Drugs Market by Product Type
9.4.5.1.2 South Africa Cancer Treatment Drugs Market by Application
9.4.5.2 Saudi Arabia Cancer Treatment Drugs Market
9.4.5.2.1 Saudi Arabia Cancer Treatment Drugs Market by Product Type
9.4.5.2.2 Saudi Arabia Cancer Treatment Drugs Market by Application
9.4.5.3 U.A.E Cancer Treatment Drugs Market
9.4.5.3.1 U.A.E Cancer Treatment Drugs Market by Product Type
9.4.5.3.2 U.A.E Cancer Treatment Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cancer Treatment Drugs Market Overview
9.5.2 South and Central America Cancer Treatment Drugs Market Forecasts and Analysis
9.5.3 South and Central America Cancer Treatment Drugs Market Forecasts and Analysis - By Product Type
9.5.4 South and Central America Cancer Treatment Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cancer Treatment Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cancer Treatment Drugs Market
9.5.5.1.1 Brazil Cancer Treatment Drugs Market by Product Type
9.5.5.1.2 Brazil Cancer Treatment Drugs Market by Application
9.5.5.2 Argentina Cancer Treatment Drugs Market
9.5.5.2.1 Argentina Cancer Treatment Drugs Market by Product Type
9.5.5.2.2 Argentina Cancer Treatment Drugs Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CANCER TREATMENT DRUGS MARKET, KEY COMPANY PROFILES
11.1. ABBVIE INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ASTELLAS PHARMA INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTRAZENECA PLC
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BRISTOL-MYERS SQUIBB COMPANY
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. CELGENE CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. F. HOFFMANN-LA ROCHE LTD.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. JOHNSON AND JOHNSON (JANSSEN GLOBAL SERVICES, LLC,)
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. MERCK AND CO. INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. NOVARTIS AG
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. PFIZER INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AbbVie Inc.
2. Astellas Pharma Inc.
3. AstraZeneca PLC
4. Bristol-Myers Squibb Company
5. Celgene Corporation
6. F Hoffmann-La Roche ltd.
7. Johnson & Johnson (Janssen Global Services, LLC,)
8. Merck & Co., Inc.
9. Novartis AG
10. Pfizer Inc
TIPRE00008658
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking